Login / Signup
Aysun Kucukoz Uzun
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 3
Top Topics
Peritoneal Dialysis
Low Cost
Advanced Non Small Cell Lung Cancer
Prognostic Factors
Top Venues
Cancers
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Sedat Yildirim
,
Akif Dogan
,
Goncagul Akdag
,
Eyyüp Cavdar
,
Oguzcan Kinikoglu
,
Sila Oksuz
,
Hacer Sahika Yildiz
,
Aysun Kucukoz Uzun
,
Deniz Işık
,
Heves Surmeli
,
Tugba Basoglu Tuylu
,
Ozlem Nuray Sever
,
Hatice Odabaş
,
Mahmut Emre Yildirim
,
Nedim Turan
A Novel Prognostic Indicator for Immunotherapy Response: Lymphocyte-to-Albumin (LA) Ratio Predicts Survival in Metastatic NSCLC Patients.
Cancers
16 (14) (2024)
Sedat Yildirim
,
Akif Dogan
,
Goncagul Akdag
,
Eyyüp Cavdar
,
Oguzcan Kinikoglu
,
Sila Oksuz
,
Hacer Sahika Yildiz
,
Aysun Kucukoz Uzun
,
Deniz Işık
,
Heves Surmeli
,
Tugba Basoglu Tuylu
,
Ozlem Nuray Sever
,
Hatice Odabaş
,
Mahmut Emre Yildirim
,
Nedim Turan
A Novel Prognostic Indicator for Immunotherapy Response: Lymphocyte-to-Albumin (LA) Ratio Predicts Survival in Metastatic NSCLC Patients.
Cancers
16 (14) (2024)
Sedat Yildirim
,
Akif Dogan
,
Goncagul Akdag
,
Eyyüp Cavdar
,
Oguzcan Kinikoglu
,
Sila Oksuz
,
Hacer Sahika Yildiz
,
Aysun Kucukoz Uzun
,
Deniz Işık
,
Heves Surmeli
,
Tugba Basoglu Tuylu
,
Ozlem Nuray Sever
,
Hatice Odabaş
,
Mahmut Emre Yildirim
,
Nedim Turan
A Novel Prognostic Indicator for Immunotherapy Response: Lymphocyte-to-Albumin (LA) Ratio Predicts Survival in Metastatic NSCLC Patients.
Cancers
16 (14) (2024)